Activation of acid sphingomyelinase and its inhibition by the nitric oxide/cyclic guanosine 3',5'-monophosphate pathway: key events in Escherichia coli-elicited apoptosis of dendritic cells.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMID 15383576)

Published in J Immunol on October 01, 2004

Authors

Sestina Falcone1, Cristiana Perrotta, Clara De Palma, Addolorata Pisconti, Clara Sciorati, Annalisa Capobianco, Patrizia Rovere-Querini, Angelo A Manfredi, Emilio Clementi

Author Affiliations

1: Vita-Salute University and Stem Cell Research Institute, San Raffaele, Milan, Italy.

Articles citing this

Acid sphingomyelinase activity triggers microparticle release from glial cells. EMBO J (2009) 1.78

DC-SIGN mediated sphingomyelinase-activation and ceramide generation is essential for enhancement of viral uptake in dendritic cells. PLoS Pathog (2011) 1.00

Syntaxin 4 is required for acid sphingomyelinase activity and apoptotic function. J Biol Chem (2010) 0.97

Studies on the role of acid sphingomyelinase and ceramide in the regulation of tumor necrosis factor alpha (TNFalpha)-converting enzyme activity and TNFalpha secretion in macrophages. J Biol Chem (2010) 0.95

Converging roles for sphingolipids and cell stress in the progression of neuro-AIDS. Front Biosci (2008) 0.92

A failure to normalize biochemical and metabolic insults during morphine withdrawal disrupts synaptic repair in mice transgenic for HIV-gp120. J Neuroimmune Pharmacol (2011) 0.91

Inhibition of acid sphingomyelinase by tricyclic antidepressants and analogons. Front Physiol (2014) 0.91

Nitric oxide and cGMP protein kinase (cGK) regulate dendritic-cell migration toward the lymph-node-directing chemokine CCL19. Blood (2005) 0.90

Nitric oxide controls an inflammatory-like Ly6C(hi)PDCA1+ DC subset that regulates Th1 immune responses. J Leukoc Biol (2010) 0.87

Acid sphingomyelinase in macrophage biology. Cell Mol Life Sci (2011) 0.84

Deficient nitric oxide signalling impairs skeletal muscle growth and performance: involvement of mitochondrial dysregulation. Skelet Muscle (2014) 0.84

Nitric oxide-sphingolipid interplays in plant signalling: a new enigma from the Sphinx? Front Plant Sci (2013) 0.82

Alterations of dendritic cells in sepsis: featured role in immunoparalysis. Biomed Res Int (2015) 0.82

The Role of ATP-Binding Cassette Transporters in Neuro-Inflammation: Relevance for Bioactive Lipids. Front Pharmacol (2012) 0.78

Types A and B Niemann-Pick disease. Mol Genet Metab (2016) 0.77

Nitric oxide released from JS-K induces cell death by mitotic catastrophe as part of necrosis in glioblastoma multiforme. Cell Death Dis (2016) 0.76

Defining a role for acid sphingomyelinase in the p38/interleukin-6 pathway. J Biol Chem (2014) 0.76

Tetanus Toxin Hc Fragment Induces the Formation of Ceramide Platforms and Protects Neuronal Cells against Oxidative Stress. PLoS One (2013) 0.76

ATF3 reduces migration capacity by regulation of matrix metalloproteinases via NFκB and STAT3 inhibition in glioblastoma. Cell Death Discov (2017) 0.75

A Comparison of the Effects of Neuronal Nitric Oxide Synthase and Inducible Nitric Oxide Synthase Inhibition on Cartilage Damage. Biomed Res Int (2016) 0.75

Articles by these authors

Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science (2005) 6.69

Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science (2003) 6.66

Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat Med (2010) 4.61

High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol Rev (2007) 3.23

Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J Immunol (2005) 3.05

HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep (2004) 3.00

Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med (2008) 2.97

The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol (2010) 2.93

Flow cytometric analysis of inflammatory cells in ischemic rat brain. Stroke (2002) 2.50

Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals. Proc Natl Acad Sci U S A (2004) 2.44

HMGB1: guiding immunity from within. Trends Immunol (2005) 2.42

TNF-alpha downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents. J Clin Invest (2006) 2.04

On the possible interaction between vaccines and drugs. Eur J Clin Pharmacol (2013) 1.99

Kawasaki disease and pertussis epidemics. Epidemiology (2014) 1.97

Paroxysmal Sympathetic Hyperactivity in Pediatric Rehabilitation: Clinical Factors and Acute Pharmacological Management. J Head Trauma Rehabil (2015) 1.96

HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment. Proc Natl Acad Sci U S A (2008) 1.80

Acid sphingomyelinase activity triggers microparticle release from glial cells. EMBO J (2009) 1.78

Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy. Proc Natl Acad Sci U S A (2006) 1.69

Macropinocytosis: regulated coordination of endocytic and exocytic membrane traffic events. J Cell Sci (2006) 1.64

Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells. Eur J Immunol (2005) 1.63

Defective mitochondrial biogenesis: a hallmark of the high cardiovascular risk in the metabolic syndrome? Circ Res (2007) 1.62

Identification and predictive value of interleukin-6+ interleukin-10+ and interleukin-6- interleukin-10+ cytokine patterns in ST-elevation acute myocardial infarction. Circ Res (2012) 1.55

The secretion of HMGB1 is required for the migration of maturing dendritic cells. J Leukoc Biol (2006) 1.53

Inflammatory and alternatively activated human macrophages attract vessel-associated stem cells, relying on separate HMGB1- and MMP-9-dependent pathways. J Leukoc Biol (2009) 1.51

Limited sampling strategies for the estimation of atazanavir daily exposure in HIV-infected patients. Fundam Clin Pharmacol (2011) 1.38

Polarization dictates iron handling by inflammatory and alternatively activated macrophages. Haematologica (2010) 1.36

Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease. Am J Pathol (2009) 1.33

Circulating CD4+CD25hiCD127lo regulatory T-Cell levels do not reflect the extent or severity of carotid and coronary atherosclerosis. Arterioscler Thromb Vasc Biol (2010) 1.33

Maturing dendritic cells depend on RAGE for in vivo homing to lymph nodes. J Immunol (2008) 1.32

Immunology. Dangers in and out. Science (2009) 1.32

Low hepcidin accounts for the proinflammatory status associated with iron deficiency. Blood (2011) 1.31

Endothelial nitric oxide synthase activation by tumor necrosis factor alpha through neutral sphingomyelinase 2, sphingosine kinase 1, and sphingosine 1 phosphate receptors: a novel pathway relevant to the pathophysiology of endothelium. Arterioscler Thromb Vasc Biol (2005) 1.31

Neutrophils phagocytose activated platelets in vivo: a phosphatidylserine, P-selectin, and {beta}2 integrin-dependent cell clearance program. Blood (2009) 1.29

Effector Memory T cells Are Associated With Atherosclerosis in Humans and Animal Models. J Am Heart Assoc (2012) 1.29

Early and transient release of leukocyte pentraxin 3 during acute myocardial infarction. J Immunol (2011) 1.28

Retracted Follistatin induction by nitric oxide through cyclic GMP: a tightly regulated signaling pathway that controls myoblast fusion. J Cell Biol (2006) 1.25

Pentraxins, humoral innate immunity and tissue injury. Curr Opin Immunol (2008) 1.24

Inter- and intra-patient variability of raltegravir pharmacokinetics in HIV-1-infected subjects. J Antimicrob Chemother (2011) 1.22

HMGB1: a two-headed signal regulating tumor progression and immunity. Curr Opin Immunol (2008) 1.21

Immune regulatory neural stem/precursor cells protect from central nervous system autoimmunity by restraining dendritic cell function. PLoS One (2009) 1.21

Requirement of HMGB1 for stromal cell-derived factor-1/CXCL12-dependent migration of macrophages and dendritic cells. J Leukoc Biol (2009) 1.21

The immune system and the repair of skeletal muscle. Pharmacol Res (2008) 1.20

Microvesicles released from microglia stimulate synaptic activity via enhanced sphingolipid metabolism. EMBO J (2012) 1.16

Inhibition of phosphatidylserine recognition heightens the immunogenicity of irradiated lymphoma cells in vivo. J Exp Med (2004) 1.15

Requirement of dying cells and environmental adjuvants for the induction of autoimmunity. Arthritis Rheum (2004) 1.13

Pentraxin-3 as a marker of disease activity in Takayasu arteritis. Ann Intern Med (2011) 1.12

On the association between human papillomavirus vaccine and primary ovarian failure. Am J Reprod Immunol (2013) 1.11

Mitochondrial biogenesis as a cellular signaling framework. Biochem Pharmacol (2004) 1.09

Necdin mediates skeletal muscle regeneration by promoting myoblast survival and differentiation. J Cell Biol (2007) 1.08

Macrophages in injured skeletal muscle: a perpetuum mobile causing and limiting fibrosis, prompting or restricting resolution and regeneration. Front Immunol (2011) 1.08

Cutting edge: dissociation between autoimmune response and clinical disease after vaccination with dendritic cells. J Immunol (2003) 1.08

The first ALS2 missense mutation associated with JPLS reveals new aspects of alsin biological function. Brain (2006) 1.07

Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study. Rheumatology (Oxford) (2011) 1.06

Selective up-regulation of the soluble pattern-recognition receptor pentraxin 3 and of vascular endothelial growth factor in giant cell arteritis: relevance for recent optic nerve ischemia. Arthritis Rheum (2012) 1.04

High-mobility group box 1 release and redox regulation accompany regeneration and remodeling of skeletal muscle. Antioxid Redox Signal (2011) 1.03

Abcg2 labels multiple cell types in skeletal muscle and participates in muscle regeneration. J Cell Biol (2011) 1.02

Ex vivo treatment with nitric oxide increases mesoangioblast therapeutic efficacy in muscular dystrophy. J Cell Sci (2006) 1.02

High-mobility group box 1 (HMGB1) as a master regulator of innate immunity. Cell Tissue Res (2010) 1.02

Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with gram-positive infections. Int J Antimicrob Agents (2013) 1.02

The low-affinity receptor for neurotrophins p75NTR plays a key role for satellite cell function in muscle repair acting via RhoA. Mol Biol Cell (2009) 1.02

The tissue pentraxin PTX3 limits C1q-mediated complement activation and phagocytosis of apoptotic cells by dendritic cells. J Leukoc Biol (2006) 1.01